Filing search / Iovance Biotherapeutics, Inc. / "Tax" / Page 6

8-K

EX-99.1

yoy54 xjhanhgvwugj

25 Feb 20

Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2019

4:10pm

8-K

EX-99.1

s62kw 6kh6obdbl

4 Nov 19

Iovance Biotherapeutics Reports Third Quarter and September Year-to-Date 2019 Financial Results

4:05pm

8-K

EX-99.1

d6xbev6f4g2j1x

1 Aug 19

Iovance Biotherapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

4:06pm

8-K

EX-99.1

yny8ndvej57vu

2 Jul 19

July 2019 © 2019, Iovance Biotherapeutics, Inc. Investigating the Power of Tumor Infiltrating Lymphocytes for Treatment of Solid Tumors

8:00am

8-K

EX-99.2

r1w11 cye

2 Jul 19

July 2019 © 2019, Iovance Biotherapeutics, Inc. Investigating the Power of Tumor Infiltrating Lymphocytes for Treatment of Solid Tumors

8:00am

8-K

EX-99.1

840h1qqertzd2h7wj

11 Jun 19

Iovance Biotherapeutics Appoints Athena Countouriotis, M.D., to Board of Directors

8:00am

8-K

EX-10.1

y0wd7 4n8n3ac

3 Jun 19

June 2019 © 2019, Iovance Biotherapeutics, Inc. Corporate Presentation

4:30pm

8-K

EX-99.1

g6se7rx 2boggpyws0f

22 May 19

Other Events

4:40pm